While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...

"You’re really quickly drawn into a duel," said the singer. "I guess that’s the way you find out what you’re made of." ...

Nivolumab is a monoclonal antibody that works by binding to a protein called PD-1 on a type of immune cell called T-cell.

The ability of mutations to cause cancer depends on how fast they force cells to divide, Sinai Health researchers have found.

Michael Bolton opened up for the first time about his battle with glioblastoma, a rare and aggressive form of brain cancer, over a year after sharing his brain tumor diagnosis.

Princess Margaret Cancer Center at University Health Network-led researchers constructed a detailed single-cell atlas of ...

Makeup artist Charlie Hounslow's family are raising money for treatment after she was diagnosed with glioblastoma ...

Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...

Monitoring blood levels of circulating tumor DNA in patients with stage 3 melanoma may accurately predict skin cancer ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Michael Bolton, 72, reflects on his glioblastoma brain cancer diagnosis, surgery and recovery journey with his family's support ...

Positive results of PARP inhibitor and CAR T-cell treatments highlight advances in research for neuroblastoma.